SynthesisReviews in cardiovascular medicine2023

Risk of Cardiovascular Events with Cyclin-Dependent Kinases 4 and 6 (CDK 4/6) Inhibitors among Patients with Advanced Breast Cancer: A Systematic Review and Network Meta-Analysis.

Yi-Shao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.